Hereditary angioedema (HAE) is undoubtedly an autosomal dominant problem attributable to a deficient or nonfunctional C1 esterase inhibitor (C1 INH) and clinically characterized by episodes of swelling of the facial area, extremities, genitalia, bowel wall, and higher respiratory tract. In tiny scale clinical experiments, stanozolol was productive